AUXINS AND INDOLES
1-ACETYL-5-BROMOINDOL-3-OL (1Ac5BrI) [1-acetyl-5-bromo-3-hydroxyindole]
|
MW 254.08; crystalline; purity > 95% (HPLC) |
|
CAS: 114165-30-9; C10H8BrNO2 |
|
|
003 5511 |
100 |
mg |
|
003 5512 |
250 |
mg |
|
003 5513 |
1 |
g |
5-BROM-3-INDOLYL-β-D-GLUCOPYRANOSIDE (Bluo-Glu)
[2-(5-bromo-1H-indol-3-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol]
|
MW 374.19; crystalline; purity > 98% (HPLC) |
|
CAS: 16934-09-1; C14H16BrNO6 |
|
|
003 6321 |
10 |
mg |
|
003 6322 |
50 |
mg |
|
003 6323 |
100 |
mg |
4-CHLOROINDOLE-3-ACETIC ACID (4ClIAA)
|
MW 209.63; crystalline; purity > 98% (HPLC) |
|
CAS: 2519-61-1; C10H8CINO2 |
|
|
003 1131 |
10 |
mg |
|
003 1132 |
50 |
mg |
|
003 1133 |
100 |
mg |
Natural auxin
5-CHLOROINDOLE-3-ACETIC ACID (5ClIAA)
|
MW 209.63; crystalline; purity > 98% (HPLC) |
|
CAS: 1912-45-4; C10H18ClNO2 |
|
|
003 1181 |
10 |
mg |
|
003 1182 |
50 |
mg |
|
003 1183 |
100 |
mg |
|
003 1184 |
1 |
g |
2,3-DIHYDRO-2-OXO-INDOLE-3-ACETATE-GLUCOSYL ESTER (oxIAA-Glc) [1-(2,3-Dihydro-2-oxo-1H-indole-3-acetate)-β-D-glucopyranose]
|
MW 353.33; crystalline; purity > 98% (HPLC) |
|
CAS: 945774-92-5; C16H19NO8 |
|
|
003 7321 |
1 |
mg |
|
003 7322 |
2 |
mg |
|
003 7323 |
5 |
mg |
5-FLUOROINDOLE-3-ACETIC ACID (5FIAA)
|
MW 193.18; crystalline; purity > 98% (HPLC) |
|
CAS: 443-73-2; C10H8FNO2 |
|
| 003 1251 |
100 |
mg |
| 003 1252 |
250 |
mg |
| 003 1253 |
1 |
g |
5-HYDROXYINDOLE-3-ACETIC ACID (5OHIAA)
|
MW 191.19; crystalline; purity > 98% (HPLC) |
|
CAS: 54-16-0; C10H9N03 |
|
| 003 1381 |
100 |
mg |
| 003 1382 |
250 |
mg |
| 003 1383 |
1 |
g |
5-HYDROXYTRYPTOPHOL (5OHIEt) [2-(5-hydroxy-3-indolyl)ethanol]
|
MW 177.20; crystalline; purity > 98% (HPLC) |
|
S:26, 36; CAS: 154-02-9; C10H11NO2 |
|
|
003 1511 |
100 |
mg |
| 003 1512 |
250 |
mg |
| 003 1513 |
1 |
g |
INDOLE-3-ACETIC ACID (IAA) [3-indolylacetic acid]
|
MW 175.19; crystalline; purity > 98% (HPLC) |
|
CAS: 87-51-4; C10H9NO2 |
|
| 003 1531 |
5 |
g |
| 003 1532 |
25 |
g |
| 003 1533 |
100 |
g |
INDOLE-3-ACETAMIDE (IAM)
|
MW 174.20; crystalline; purity > 98% (HPLC) |
|
CAS: 879-37-8; C10H10N2O |
|
|
003 1541 |
100 |
mg |
|
003 1542 |
250 |
mg |
|
003 1543 |
1 |
g |
INDOLE-3-ACETIC ACID METHYL ESTER (IAAMe) [methyl indole-3-acetate]
|
MW 189.22; crystalline; purity > 98% (HPLC) |
|
CAS: 1912-33-0; C11H11NO2 |
|
|
003 1551 |
5 |
mg |
|
003 1552 |
10 |
mg |
|
003 1553 |
25 |
mg |
INDOLE-3-ACETIC ACID ETHYL ESTER (IAAEt) [ethyl indole-3-acetate]
|
MW 203.24; crystalline; purity > 98% (HPLC) |
|
CAS: 778-82-5; C12H13NO2 |
|
|
003 1561 |
5 |
mg |
|
003 1562 |
10 |
mg |
|
003 1563 |
25 |
mg |
INDOLE-3-ACETONE (IAc)
|
MW 173.22; crystalline; purity > 98% (HPLC) |
|
CAS: 1201-26-9; C11H11NO |
|
|
003 1571 |
100 |
mg |
|
003 1572 |
250 |
mg |
|
003 1573 |
1 |
g |
INDOLE-3-ACETONITRILE (IAN) [indole-3-acetonitrile]
|
MW 156.19; crystalline; purity > 98% (HPLC) |
|
CAS: 771-51-7; C10H8N2 |
|
|
003 1851 |
1 |
g |
|
003 1852 |
5 |
g |
|
003 1853 |
25 |
g |
INDOLE-3-ACETYL-1-GLUCOSYL ESTER (IAA-Glc) [N-(3-indolylacetyl)-β-D-glucopyranose]
|
MW 337.33; crystalline; purity > 98% (HPLC) |
|
CAS: 19817-95-9; C16H19NO7 |
|
|
003 7311 |
1 |
mg |
|
003 7312 |
2 |
mg |
|
003 7313 |
5 |
mg |
INDOLE-3-ACETYL-L-ALANINE (IAAla)
[N-(3-indolylacetyl)-L-alanine]
|
MW 246.27; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-39-2; C13H14N2O3 |
|
|
003 1581 |
5 |
mg |
|
003 1582 |
10 |
mg |
|
003 1583 |
25 |
mg |
INDOLE-3-ACETYL-L-ALANINE METHYL ESTER (IAAlaMe)
[N-(3-indolylacetyl)-L-alanine methyl ester]
|
MW 260.30; crystalline; purity > 98% (HPLC) |
|
CAS: 109708-25-0; C14H16N2O3 |
|
|
003 5351 |
5 |
mg |
|
003 5352 |
10 |
mg |
|
003 5353 |
25 |
mg |
INDOLE-3-ACETYL-L-ASPARTIC ACID (IAAsp)
[N-(3-indolylacetyl)-L-aspartic acid]
|
MW 290.28; crystalline; purity > 98% (HPLC) |
|
CAS: 2456-73-7; C14H14N2O5 |
|
|
003 1591 |
5 |
mg |
|
003 1592 |
10 |
mg |
|
003 1593 |
25 |
mg |
INDOLE-3-ACETYL-L-ASPARTIC ACID DIMETHYL ESTER (IAAspMe)
[N-(3-indolylacetyl)-L-aspartic acid dimethyl ester]
|
MW 318.33; crystalline; purity > 98% (HPLC) |
|
CAS: 107619-05-6; C16H18N2O5 |
|
|
003 5361 |
5 |
mg |
|
003 5362 |
10 |
mg |
|
003 5363 |
25 |
mg |
INDOLE-3-ACETYL-L-GLUTAMIC ACID (IAGlu) [N-(3-indolylacetyl)-L-glutamic acid]
|
MW 304.31; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-48-3; C15H16N2O5 |
|
|
003 6131 |
5 |
mg |
|
003 6132 |
10 |
mg |
|
003 6133 |
25 |
mg |
INDOLE-3-ACETYL-L-GLUTAMIC ACID DIMETHYL ESTER (IAGluMe) [N-(3-indolylacetyl)-L-glutamic acid dimethyl
ester]
|
MW 332.36; crystalline; purity > 98% (HPLC) |
|
CAS: NONE; C17H20N2O5 |
|
|
003 6141 |
5 |
mg |
|
003 6142 |
10 |
mg |
|
003 6143 |
25 |
mg |
INDOLE-3-ACETYL-GLYCINE (IAGLY)
|
MW 232.24; crystalline; purity > 98% (HPLC) |
|
CAS: 13113-08-1; C12H12N2O3 |
|
|
003 7011 |
5 |
mg |
|
003 7012 |
10 |
mg |
|
003 7013 |
25 |
mg |
INDOLE-3-ACETYL-L-ISOLEUCINE (IAILeu) [N-(3-indolylacetyl)-L-isoleucine]
|
MW 288.35; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-45-0; C16H20N2O3 |
|
|
003 1601 |
5 |
mg |
|
003 1602 |
10 |
mg |
|
003 1603 |
25 |
mg |
INDOLE-3-ACETYL-L-ISOLEUCINE METHYL ESTER (IAIleuMe) [N-(3-indolylacetyl)-L-isoleucine methyl
ester]
|
MW 302.38; crystalline; purity > 98% (HPLC) |
|
CAS: 66642-42-0; C17H22N2O3 |
|
|
003 5371 |
5 |
mg |
|
003 5372 |
10 |
mg |
|
003 5373 |
25 |
mg |
INDOLE-3-ACETYL-L-LEUCINE (IALeu)
[N-(3-indolylacetyl)-L-leucine]
|
MW 288.35; crystalline; purity > 98% (HPLC) |
|
CAS: 36838-63-8; C16H20N2O3 |
|
|
003 1611 |
5 |
mg |
|
003 1612 |
10 |
mg |
|
003 1613 |
25 |
mg |
INDOLE-3-ACETYL-L-LEUCINE METHYL ESTER (IALeuMe)
[N-(3-indolylacetyl)-L-leucine methyl ester]
|
MW 302.38; oil; purity > 98% (HPLC) |
|
CAS: 30372-97-3; C17H22N2O3 |
|
|
003 5381 |
5 |
mg |
|
003 5382 |
10 |
mg |
|
003 5383 |
25 |
mg |
INDOLE-3-ACETYL-L-PHENYLALANINE (IAPhe) [N-(3-indolylacetyl)-L-phenylalanine]
|
MW 322.37; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-50-7; C19H18N2O3 |
|
|
003 1621 |
5 |
mg |
|
003 1622 |
10 |
mg |
|
003 1623 |
25 |
mg |
INDOLE-3-ACETYL-L-PHENYLALANINE METHYL ESTER (IAPheMe) [N-(3-indolylacetyl)-L-phenylalanine methyl ester]
|
MW 336.39; crystalline; purity > 98% (HPLC) |
|
CAS: 1060809-98-4; C20H20N2O3 |
|
|
003 5391 |
5 |
mg |
|
003 5392 |
10 |
mg |
|
003 5393 |
25 |
mg |
INDOLE-3-ACETYL-L-TRYPTOPHAN (IATrp)
[N-(3-indolylacetyl)-L-tryptophan]
|
MW 361.40; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-53-0; C21H19N3O3 |
|
|
003 1631 |
5 |
mg |
|
003 1632 |
10 |
mg |
|
003 1633 |
25 |
mg |
INDOLE-3-ACETYL-L-TRYPTOPHAN METHYL ESTER (IATrpMe)
[N-(3-indolylacetyl)-L-tryptophan methyl ester]
|
MW 375.43; crystalline; purity > 98% (HPLC) |
|
CAS: 352694-96-3; C22H21N3O3 |
|
|
003 5401 |
5 |
mg |
|
003 5402 |
10 |
mg |
|
003 5403 |
25 |
mg |
INDOLE-3-ACETYL-L-VALINE (IAVal) [N-(3-indolylacetyl)-L-valine]
|
MW 274.32; crystalline; purity > 98% (HPLC) |
|
CAS: 57105-42-7; C15H18N2O3 |
|
|
003 1641 |
5 |
mg |
|
003 1642 |
10 |
mg |
|
003 1643 |
25 |
mg |
INDOLE-3-ACETYL-L-VALINE METHYL ESTER (IAValMe) [N-(3-indolylacetyl)-L-valine methyl ester]
|
MW 288.35; crystalline; purity > 98% (HPLC) |
|
CAS: 1308991-15-2; C16H20N2O3 |
|
|
003 5411 |
5 |
mg |
|
003 5412 |
10 |
mg |
|
003 5413 |
25 |
mg |
INDOLE-3-BUTYRAMIDE (IBAM)
| MW 202.26; crystalline; purity > % (HPLC) |
|
CAS: 6245-91-6; C12H14N2O
|
|
| 003 6611 |
1 |
mg |
| 003 6612 |
5 |
mg |
| 003 6613 |
10 |
mg |
(3Z)-1H-INDOLE-2,3-DIONE 3-[N-(4-METHOXYPHENYL)THIOSEMICARBAZO-NE [2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-N-(4-methoxyphenyl)-hydrazinecarbothioamide]
| MW 326.38; crystalline; purity > 98% (HPLC) |
|
CAS: 79560-74-0; C16H14N4O2S
|
|
| 003 6631 |
1 |
mg |
| 003 6632 |
5 |
mg |
| 003 6633 |
10 |
mg |
INDOLE-3-BUTYRIC ACID (IBA) [4-(3-indolyl)butyric acid]
|
MW 203.24; crystalline; purity > 98% (HPLC) |
|
CAS: 133-32-4; C12H13NO2 |
|
|
003 1661 |
1 |
g |
|
003 1662 |
5 |
g |
|
003 1663 |
25 |
g |
INDOLE-3-BUTYRIC ACID POTASSIUM SALT (IBA-K) [4-(3-indolyl)butyric acid potassium
salt]
|
MW
241.34; crystalline; purity > 98% (HPLC) |
|
CAS: 60096-23-3; C12H12KNO2 |
|
|
003 6281 |
1 |
g |
|
003 6282 |
5 |
g |
|
003 6283 |
25 |
g |
INDOLE-3-BUTYRIC ACID METHYL ESTER (IBAMe) [4-(3-indolyl)butyric acid methyl ester]
|
MW 217.27; crystalline; purity > 98% (HPLC) |
|
CAS: 15591-70-5; C13H15NO2 |
|
|
003 5431 |
10 |
mg |
|
003 5432 |
50 |
mg |
|
003 5433 |
100 |
mg |
INDOLE-3-BUTYRYL -L-ALANINE (IBAla) [N-(3-indolylbutyryl)-L-alanine]
|
MW 274.32; crystalline; purity > 93 % (HPLC |
|
CAS: 118546-30-8; C15H18N2O3 |
|
|
003 6551 |
1 |
mg |
|
003 6552 |
5 |
mg |
|
003 6553 |
10 |
mg |
INDOLE-3-BUTYRYL -L-ASPARTIC ACID (IBAsp)[N-(3 indolylbutyryl)-L-aspartic acid]
|
MW 318.33; crystalline; purity > % (HPLC) |
|
CAS: 101289-65-0; C16H18N2O5 |
|
|
003 6561 |
1 |
mg |
|
003 6562 |
5 |
mg |
|
003 6563 |
10 |
mg |
INDOLE-3-BUTYRYL-L-GLUTAMIC ACID (IBGlu) [N-(3-indolylbutyryl)-L-glutamic acid]
|
MW
332.36; crystalline; purity > 98% (HPLC) |
|
CAS: 1188364-93-3; C17H20N2O5 |
|
|
003 6491 |
1 |
mg |
|
003 6492 |
5 |
mg |
|
003 6493 |
10 |
mg |
INDOLE-3-BUTYRYL GLYCINE (IBGly) [N-(3-indolylbutyryl)-L-glycine]
|
MW
260.30; crystalline; purity > % (HPLC) |
|
CAS: 796072-70-3; C14H16N2O3 |
|
|
003 6601 |
1 |
mg |
|
003 6602 |
5 |
mg |
|
003 6603 |
10 |
mg |
INDOLE-3-BUTYRYL-L-LEUCINE (IBLeu)
[N-(3-indolylbutyryl)-L-leucine ]
|
MW
316.40; crystalline; purity > 95% (HPLC) |
|
CAS: 1009593-81-0; C18H24N2O3 |
|
|
003 6501 |
1 |
mg |
|
003 6502 |
5 |
mg |
|
003 6503 |
10 |
mg |
INDOLE-3-BUTYRYL-L-PHENYLALANINE (IBPhe) [N-(3-indolylbutyryl)-L-phenylalanine]
|
MW
350.42; crystalline; purity > 95% (HPLC) |
|
CAS: 1008303-39-6; C21H22N2O3 |
|
|
003 6511 |
1 |
mg |
|
003 6512 |
5 |
mg |
|
003 6513 |
10 |
mg |
INDOLE-3-BUTYRYL -L-TRYPTOPHAN (IBTrp)[N-(3- indolylbutyryl)-L-tryptophan]
|
MW
389.46; crystalline; purity > 98% (HPLC) |
|
CAS: 406726-77-0; C23H23N3O3 |
|
|
003 6571 |
1 |
mg |
|
003 6572 |
5 |
mg |
|
003 6573 |
10 |
mg |
INDOLE-3-BUTYRYL-L-VALINE (IBVal) [N-(3-indolylbutyryl)-L-valine]
|
MW 302.38; crystalline; purity > 93% (HPLC) |
|
CAS: 1008923-22-5; C17H22N2O3 |
|
|
003 6521 |
1 |
mg |
|
003 6522 |
5 |
mg |
|
003 6523 |
10 |
mg |
INDOLE-3-CARBOXALDEHYDE (IAld) [3-formylindole]
|
MW 145.16; crystalline; purity > 98% (HPLC) |
|
CAS: 487-89-8; C9H7NO |
|
|
003 1671 |
5 |
g |
|
003 1672 |
25 |
g |
|
003 1673 |
100 |
g |
INDOLE-3-CARBINOL (IM) [3-indolemethanol, 3-(hydroxymethyl)indole]
|
MW 147.18; crystalline; purity > 98% (HPLC) |
|
CAS: 700-06-1; C9H9NO |
|
|
003 1681 |
1 |
g |
|
003 1682 |
5 |
g |
|
003 1683 |
25 |
g |
INDOLE-3-CARBOXYLIC ACID (I3CA)
|
MW 161.16; crystalline; purity > 98% (HPLC) |
|
CAS: 771-50-6; C9H7NO2 |
|
|
003 1721 |
1 |
g |
|
003 1722 |
5 |
g |
|
003 1723 |
25 |
g |
INDOLE-3-CARBOXYLIC ACID METHYL ESTER (I3CAMe) [methyl indole-3-carboxylate]
|
MW 175.19; crystalline; purity > 98% (HPLC) |
|
CAS: 942-24-5; C10H9NO2 |
|
|
003 1731 |
1 |
g |
|
003 1732 |
5 |
g |
|
003 1733 |
25 |
g |
(3Z)-1H-INDOLE-2,3-DIONE-3-[N-(4METHOXYPHENYL)THIOSEMICARBAZO-NE [2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-N-(4-methoxyphenyl)-hydrazinecarbothioamide]
|
MW 326.38; crystalline; purity > 98% (HPLC) |
|
CAS: 79560-74-0; C16H14N4O2S |
|
|
|
003 6631 |
1 |
mg |
|
003 6632 |
5 |
mg |
|
003 6633 |
10 |
mg |
INDOLE-3-PROPIONAMIDE (IPAM)[3-(3-indolyl)propionamide]
|
MW 188.23; crystalline; purity > 98% (HPLC) |
|
CAS: 5814-93-7; C11H12N2O |
|
|
003 1821 |
100 |
mg |
|
003 1822 |
250 |
mg |
|
004 1823 |
1 |
g |
INDOLE-3-PROPIONIC ACID (IPA) [3-(3-indolyl)propionic acid]
|
MW 189.22; crystalline; purity > 98% (HPLC) |
|
CAS: 830-96-6; C11H11NO2 |
|
|
003 1831 |
1 |
g |
|
003 1832 |
5 |
g |
|
003 1833 |
25 |
g |
INDOLE-3-PYRUVIC ACID (IPiA) [3-(3-indolyl)-2-oxopropanoic acid]
|
MW 203.20; crystalline; purity > 98% (HPLC) |
|
CAS: 392-12-1; C11H9NO3 |
|
|
003 1841 |
100 |
mg |
|
003 1842 |
250 |
mg |
|
003 1843 |
1 |
g |
INDOLE-3-PYRUVIC ACID METHYL ESTER (IPiAMe) [3-(3-indolyl)-2-oxopropanoic acid methyl ester]
|
MW 217.23; crystalline; purity > 98% (HPLC) |
|
CAS: 7417-64-3; C12H11NO3 |
|
|
003 5471 |
10 |
mg |
|
003 5472 |
50 |
mg |
|
003 5473 |
100 |
mg |
3-INDOXYL-β-D-GLUCOPYRANOSIDE trihydrate (IOxGlc) [YTM-β-D-glucoside, Plant Indican]
|
MW 349.35; crystalline; purity > 98% (HPLC) |
|
CAS: 487-60-5; C14H17NO6.3H2O |
|
| 003 1881 |
10 |
mg |
| 003 1882 |
25 |
mg |
| 003 1883 |
100 |
mg |
| 003 1884 |
1 |
g |
MELATONIN (M) [N-acetyl-5-methoxytryptamine]
|
MW 232.28; crystalline; purity > 98% (HPLC) |
|
CAS: 73-31-4; C13H16N2O2 |
|
|
003 1931 |
250 |
mg |
|
003 1932 |
1 |
g |
|
003 1933 |
5 |
g |
5-METHOXYINDOLE-3-ACETIC ACID (5MeOIAA)
|
MW 205.22; crystalline; purity > 98% (HPLC) |
|
CAS: 3471-31-6; C11H11NO3 |
|
|
003 1951 |
100 |
mg |
|
003 1952 |
250 |
mg |
|
003 1953 |
1 |
g |
OXINDOLE-3-ACETIC ACID (OxIAA) [2-oxo-3-indolineacetic acid]
|
MW 191.19; crystalline; purity > 98% (HPLC) |
|
CAS: 2971-31-5; C10H9NO3 |
|
| 003 6351 |
1 |
mg |
| 003 6352 |
2 |
mg |
| 003 6353 |
5 |
mg |
2-OXINDOLE-3-ACETATYL-L-ASPARTIC ACID (oxIAAsp) [N-[2-(2,3-dihydro-2-oxo-1H-indol-3-yl)acetyl]-L-Aspartic acid]
|
MW 306.28; crystalline; purity > 95% (HPLC) |
|
CAS: 119975-53-0; C14H14N2O6 |
|
| 003 7691 |
1 |
mg |
| 003 7692 |
2 |
mg |
| 003 7693 |
5 |
mg |
2-OXINDOLE-3-ACETATYL-L-GLUTAMIC ACID (oxIAGlu) [N-[2-(2,3-dihydro-2-oxo-1H-indol-3-yl)acetyl]-L-glutamic acid]
|
MW 320.30; crystalline; purity > 98% (HPLC) |
|
CAS: ; C15H16N2O6 |
|
| 003 8151 |
1 |
mg |
| 003 8152 |
2 |
mg |
| 003 8153 |
5 |
mg |
2-OXINDOLE-3-ACETATYL-L-LEUCINE (oxIALeu) [N-[2-(2,3-dihydro-2-oxo-1H-indol-3-yl)acetyl]-L-leucine]
|
MW 304.35; crystalline; purity > 97% (HPLC) |
|
CAS: N/A; C16H20N2O4 |
|
| 003 8161 |
1 |
mg |
| 003 8162 |
2 |
mg |
| 003 8163 |
5 |
mg |
2-OXINDOLE-3-ACETATYL-L-PHENYLALANINE (oxIAPhe) [N-[2-(2,3-dihydro-2-oxo-1H-indol-3-yl)acetyl]-L-phenylalanine]
|
MW 338.37; crystalline; purity > 96% (HPLC) |
|
CAS: 945774-94-7; C19H18N2O4 |
|
| 003 8171 |
1 |
mg |
| 003 8172 |
2 |
mg |
| 003 8173 |
5 |
mg |
TRYPTOPHOL (IEt) [3-(2-hydroxyethyl)indole, indole-3-ethanol]
|
MW 161.21; crystalline; purity > 98% (HPLC) |
|
CAS: 526-55-6; C10H11NO |
|
| 003 2291 |
1 |
g |
| 003 2292 |
5 |
g |
| 003 2293 |
25 |
g |